Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

CM Wernette, CE Frasch, D Madore… - Clinical and Vaccine …, 2003 - Am Soc Microbiol
Streptococcus pneumoniae is a major human pathogen causing pneumonia, sepsis,
meningitis, and otitis media (12). It causes infections most often in young children (12) and …

Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines

TQ Tan - Clinical microbiology reviews, 2012 - Am Soc Microbiol
Invasive infections caused by Streptococcus pneumoniae continue to be a major cause of
morbidity and mortality worldwide, especially in children under 5 years of age. In the United …

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I

WP Hausdorff, J Bryant, PR Paradiso… - Clinical Infectious …, 2000 - academic.oup.com
We analyzed> 70 recent data sets to compare the serogroups causing invasive
pneumococcal disease (IPD) with those represented in conjugate vaccine formulations. Five …

Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection

R Malley, P Henneke, SC Morse… - Proceedings of the …, 2003 - National Acad Sciences
Streptococcus pneumoniae is one of the leading causes of invasive bacterial disease
worldwide. Fragments of the cell wall and the cytolytic toxin pneumolysin have been shown …

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

KA Robinson, W Baughman, G Rothrock, NL Barrett… - Jama, 2001 - jamanetwork.com
ContextPneumococcal polysaccharide vaccine is recommended for elderly persons and
adults with certain chronic illnesses. Additionally, a recently licensed pneumococcal 7-valent …

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the …

LA Mandell, TJ Marrie, RF Grossman… - Clinical Infectious …, 2000 - academic.oup.com
Methods A committee was established that was composed of members from both the CIDS
and CTS, plus additional colleagues from the United States with strong interests in CAP. The …

[HTML][HTML] Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the …

LM Mofenson, MT Brady, SP Danner… - MMWR Recomm …, 2009 - cdc.gov
This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …

Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and …

M Arditi, EO Mason Jr, JS Bradley, TQ Tan… - …, 1998 - publications.aap.org
Objectives. To evaluate the antibiotic susceptibility of Streptococcus pneumoniae isolates
obtained from the blood and cerebrospinal fluid of children with meningitis. To describe and …

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004

SS Huang, R Platt, SL Rifas-Shiman, SI Pelton… - …, 2005 - publications.aap.org
Objective. The introduction of heptavalent conjugate pneumococcal vaccine (PCV7) has
raised concerns for replacement with nonvaccine serotypes in both invasive disease and …

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

WP Hausdorff, G Siber, PR Paradiso - The Lancet, 2001 - thelancet.com
The development of glycoconjugate vaccines for Streptococcus pneumoniae that are
effective in very young children has renewed interest in identification of which among the …